In view of the prevalence of D. pteronyssinus in this country and its high allergenic potency, it is considered that this mite is an important factor in allergic asthma.
Introduction
The importance of the house-dust mite as a cause of allergic disease has only recently been recognized (Voorhorst et al., 1964 (Voorhorst et al., , 1967 . The mite Dermatophtagoides pteronyssinus is found in house dust thr,oughout the world; it is about 0.3 mm. in length and produces faecal pellets which are about the same size as grass pollen grains and are also allergenic. House dust from floors may contain from 1 to 500 of these mites per gramme. Dust from the surfaces of mattresses, however, may contain a great many more, as D. pteronyssinus feeds on shed human skin scales which it finds in abundance in bedding (Maunsell et al., 1968) . Other mites are found in house dust, but Maunsell et al. found that in England and Wales D. pteronyssinus was by far the most common, being present in 82',' of the samples they examined. The highest concentrations of these mites were found in the dust from old damp houses.
We believe that house-dust allergy, promoted by this mite, is the most common cause of allergic asthma in this country, particularly in children. Other workers in this field have expressed similar views (Morrison Smith et al., 1969; Frankland, 1969; Holzel, 1969; Williams, 1969) .
Skin tests and challenge tests have been used in the investigation of allergic disease for many years. Positive skin reactions have long been known to be due to the presence in the serum of antibodies known as reagins. Recent work has established that these reagins belong to the newly recognized immunoglobulin class IgE (Bennich et al., 1968 (Squire, 1950) . The size of the diameter of the weal was noted after 15 minutes (these tests were performed on at least two occasions and the mean weal diameters were recorded). Serial dilutions of extract, in tenfold steps from 0.1 pg. to 1 mg./ml. were used, the weakest dilution to produce a weal -of more than 1 mm. being taken as the threshold strength.
Nasal challenge tests were performed by spraying the extract directly on to the nasal septum on one side with a coarse spray. Serial strengths from 10 ,g. to 1 mg./ml. were applied on alternate sides at 10-minute intervals until a reaction consisting of sneezing, watering, or blocking of the nose occurred. The weakest strength to cause a reaction was noted and the threshold dose was calculated from this and the known output (0-02 ml. per shot) of the spray.
Bronchial challenge tests were carried out with the closed circuit method (Herxheimer, 1951; McAllen, 1961 ). An extract of standard strength was introduced into the circuit by means of a nebulizer of very low output, and the dose of the antigen was varied by altering the time of inhalation. A positive immediate reaction consisted of a minimal asthmatic attack (10-20 0/, reduction of F.E.V., or F.V.C.) coming on 5 to 10 minutes after the end of the inhalation. A positive late reaction consisted of an asthmatic attack starting 4 to 12 hours after the end of the inhalation. The reproducibility of these reactions was checked by further testing at the same level of dosage. Only one test was done on any one day in order to be able to record any late reactions; in fact, the tests were done at weekly intervals. The time of inhalation was five seconds in the first instance, and was increased by doubling the exposure at each subsequent challenge until a positive reaction was obtained. If after seven tests and reaching an exposure time of 320 seconds there had been no reaction, the bronchial response was considered negative. The threshold dose was calculated from the shortest time of exposure which caused a positive reaction, the strength of the extract (1 mg./ml.), and the output of the nebulizer (0 03 ml./minute).
Leucocyte challenge tests were carried out by a modification of the method of Lichtenstein and Osler (1964) , different concentrations of antigen being used. The maximum histamine release and the concentration of antigen causing this release were recorded. The strengths of mite extract used were from 0-1 to 100 ,g./ml. of leucocyte suspension containing 2.5 million leucocytes. The details of these tests are reported elsewhere Table II . No pattern could be seen whereby the sensitivities of the various "shock organs" were related in the individual patient. The only significant relationship in the quantitative measurements was between the two in-vitro tests. This was shown by the Spierman index of rank correlation, and is discussed elsewhere .
It can be seen from Table II that the three clinical groups of patients did not show any pronounced differences one from another, both highly sensitive and weakly sensitive reactions occurring in all groups. There was no evidence that a higher bronchial sensitivity was associated with a greater severity of asthma as measured by impairment of respiratory function. It is of interest that the two patients (Cases 3 and 19) who were on steroid treatment had negative leucocyte reactions, whereas the only other pt-tient who had a negative leucocyte response was one with the weakest response to skin tests.
The control experiments on the skin, the nose, and the bronchi were uniformly negative. The in-vitro control experiments on the non-allergic subjects were negative in eight and very weakly positive in two. The serum from the five asthmatic patients which was examined for possible reaginic activity to the culture medium was found to be positive in one (Case 20 Thr. Dose = Threshold amount of solid material which produced a positive reaction.
Discussion
A different species of the genus Dermatophagoides, D. culinae (synonymous with D. farinue), which is rarely found in dust samples in this country, has been used by some authors for tests in subjects allergic to house dust. Stenius and Wide (1969) showed that positive skin tests with D. culinae extracts were related to IgE antibody in patients with house dust allergy. They and also Pepys et al. (1968) obtained positive nasal and bronchial challenge reactions with D. culinae in their patients, but quantitative measurements were not reported. Bronchial challenge tests in Switzerland on 20 patients allergic to house dust were reported by Bachofen et al. (1967) . An extract of D. pteronyssinus was used and positive reactions were obtained in half the patients. No quantitative measurements of sensitivity were reported.
In the series here reported the results of our challenge tests confirm that D. pteronyssinus extract is able to provoke reactions in the nasal mucosa and the bronchi, but, in contrast to the findings of the previous authors, our patients showed positive reactions in a much higher proportion of cases. It has already been stated that the group under study were probably heavily exposed to mites in their home environment. This may well have been a factor in their high sensitivity as compared with the Swiss patients, and the use of D. pteronyssinus instead of D. culinae might account for the higher proportion of positive reactions we obtained than did Stenius and Wide.
The quantitative results in our patients are mainly of interest in respect of their discrepancies. It is oommon clinical experience that patients with respiratory allergy may be more troubled either by asthma or by rhinitis, and it seems likelv that the reactivity thresholds of the lung and the nasal tissues would be different in the same patient. By the same reasoning the size of the skin test reaction would not be expected to be related to the sensitivity of the lung or nasal mucosa. The results of our measurements of threshold reactions confirm these observations. Patients with atopic disease since infancy and who had had infantile eczema were found to react readily to all the challenge tests; nevertheless, even in these highly allergic subjects the titres of the positive reactions were no higher than those of other patients.
The possibility that sensitization of some of the patients might have been promoted by the repeated skin, nasal, and bronchial challenge tests has to be considered. The blood samples were therefore taken before the serial in-vivo challenge tests in a random 10 patients. Some of the strongest positive serum and leuoocyte reactions were found in these 10 patients, and in only one were the blood tests weak or negative. These findings indicate that sensitization was unlikely to have been promoted by the testing procedures in the rest of the patients.
The negative tests for precipitins suggest that the late bronchial reactions seen in six patients were not mediated by precipitins (as such reactions are in allergic alveolitis) and are not manifestations of Arthus-like type III immune responses in the lung. The mechanism of these late reactions in asthmatic patients has not been established, though such reactions have been described in detail previously and have been estimated to occur in about 30%,' of patients with house dust asthma (Herxheimer, 1952; McAllen, 1Q61) . It seems possible that they may be due to cell-mediated immune responses (delayed hypersensitivity).
Perhaps the most significant finding in our experiments is that the actual amount of antigen required to produce a tissue reaction both in vitro and in vivo is so extremely small. This is of the order of 0 05 to 1 jig. in the bronchi and 0-5 to 20 ug. in the nose; it would thus be possible under natural conditions for an allergic reaction. to be caused by the inhalation of mite material such as faecal pellets or parts -of dead mites in an amount weighing less than one whole live mite.
It is concluded that the negative findings in the control tests and the high titres of sensitivity in the challenge tests on the allergic subjects establish that the mite D. pteronyssinus contains a very potent antigen. This antigen can cause high levels of reaginic antibody and can stimulate histamine release from leucocytes of sensitized patients when brought into direct contact with them in very weak dilution. It is also able to react with sensitized tissues in the skin, the nasal mucosa, and the bronchi in allergic subjects, and can cause symptoms from inhalation of very small quantities. It would therefore appear likely that the mite D. pteronyssinus is an important factor in the causation of perennial allergic asthma in this country.Summary: A study was carried out on 26 patients with respiratory allergyi due to the house-dust mite Dermatophagoides pteronyssinus and on 10 non-allergic control subjects using two in-vitro histamine release tests for assessing immediate-type allergy. The Positive results were obtained in over 90% of patients, whereas the tests were either negative or very weakly positive in the control subjects. A significant degree of correlation was found between the. two tests used, but pronounced differences were observed in a few instances.
Confirmation of the role of IgE in tissue sensitization was obtained from tests with anti-IgE serum on leucocytes. Positive reactions of patients' leucocytes were also obtained with anti-IgG, anti-IgA, and anti-IgM sera, which would suggest that antibodies belonging to these immunoglobulin classes may also play a part in immediate-type allergic reactions. 
.Introduction
The role of house-dust mites in respiratory allergy has been the subject of many recent reports (Voorhorst et al., 1967; Maunsell et al., 1968; Pepys et al., 1968; Stenius and Wide, 1969) . Dermatophagoides pteronyssinus is now considered to be one of the most important allergens. The study of immediate-type allergy to this mite by in-vitro techniques, which so far has received little attention, is the subject of this report.
Immediate-type allergy (sometimes called atopic or anaphylactic) in man is now generally believed to be mediated by reaginic antibodies which belong mainly to a distinctive class of immunoglobulin (IgE; Bennich et al., 1968) . The major manifestations of this allergy are considered to be due to the release, or production and release, of the so-called "pharmacological mediators" such as histamine and slowreacting substance of anaphylaxis. Allergy of this type, therefore, may be detected in vitro by, two main groups of tests: (1) measurement. of IgE antibodies specific to the allergen (Wide et al., 1967; Coombs et al., 1968) , and (2) elicitation of the specific release by antigen of pharmacological mediators either from cells obtained from the patient (blood leucocytes being the best example) or from normal human or primate tissues passively sensitized by incubation with the patient's serum (Lichtenstein and Osler, 1964; Assem and Schild, 1968) .
